| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |